Negotiating interests: revisiting the role of consent in newborn genetic screening by Wale, J
 
 
Wale, J. (2020) ‘Negotiating interests: revisiting the role of consent in newborn genetic 
screening’, The Society of Legal Scholars Annual Conference, University of Exeter, UK, 1 - 4 
September 2020. 
 
ResearchSPAce 
http://researchspace.bathspa.ac.uk/ 
 
Your access and use of this document is based on your acceptance of the ResearchSPAce Metadata and Data Policies, as well as 
applicable law:-https://researchspace.bathspa.ac.uk/policies.html  
Unless you accept the terms of these Policies in full, you do not have permission to download this document. 
This cover sheet may not be removed from the document. 
Please scroll down to view the document. 
Dr Jeffrey Wale
16 November 2020
Context and 
acknowledgement
• Newborn Screening (NBS)
– Bloodspot screening
• New tests:
– Tandem mass spectrometry of biochemical 
markers
– DNA extraction and analysis
– Pressure to expand
• Parental proxy consent
• Ordinary vs extraordinary times
• Acknowledgement: 
Professor Roger Brownsword (KCL)
Structure
1. Original aims and rationales of NBS
2. Proxy consent: ideal typical model
3. Contemporary NBS models
4. Decision-making in expansionary mode
5. Legitimate interests
6. Challenges, negotiating interests and 
deviation.
Aims and rationales of screening
• Wilson and Junger, Principles and practice of 
screening for disease (1968):
– Set a high bar for screening: conditions should be 
important and treatable; screening needs to be 
effective and acceptable;
– Does not speak to genetic screening;
– Does not say screening programmes should be 
based on informed consent/ proxy consent of 
parents (P) where children concerned.
Aims and rationales of NBS
‘to detect newborns with serious treatable disorders to facilitate appropriate interventions to avoid or 
ameliorate adverse outcomes. The condition sought should be an important health problem and there 
should be an accepted treatment for patients with recognized disease as well as availability of facilities 
for diagnosis and treatment. The condition to be screened must be severe, frequent, and amenable to 
easy, safe, reliable, and inexpensive laboratory diagnosis on a very large scale’ (FIGO 2009)
• Screening contexts: clinical medicine, public health 
programmes, direct-to-consumer services.
• Symptomatic and asymptomatic populations.
• Screening for benefit of others (research, family 
members, future children etc).
• Expansion to untreatable/ asymptomatic conditions?
• Complex assessment of benefit and harm.
Proxy Consent
• By necessity, children need others to make decisions on 
their behalf.
• Governance of the relationship between parents (acting on 
their behalf) and HCPs can be difficult.
• Starting point: rights based regulatory regime:
– rights-holders may alter their position vis duty-holders
– Justificatory function of consent: does not suffice to show that 
an action is right BUT prevents a complaint by consenting party 
that their has been a violation of rights.
– Assumption: consent by P (as proxy for N), should shield H from 
complaint by P and N.
– The possibility of overriding justification is recognised BUT only 
where H has a conflicting higher ranking right.
Ideal Typical Proxy Consent Model
Parents have a veto and consent is taken seriously 
as justification for action.
Conditions:
1. Consent by parents as a necessary and sufficient 
justifying condition for the proposed action. (no 
consent: prima facie violation).
2. Parents’ consent is to be treated as valid only 
where (a) explicit and clearly signalled; (b) freely 
given; (c) informed.
Parental consent should (ideally) flow from a 
relational process.
Scope of parental consent/veto
• Extent to which interests of child and others 
might constrain parental rights.
• Different interpretative approaches where 
consent is being given/ withheld on behalf of 
another?
• Pressure points - circumstantial factors:
– In ordinary times: appeals to professional duty/ 
optimisation of health to child/ community.
– In extraordinary times: appeals to responsibility/ 
solidarity/ states of exception.
Deviations and pressure
• Ways in which pressure might be applied to the ideal 
typical model:
– De-centring consent as a necessary and sufficient condition for 
justified action (condition 1);
– Diluting the particular requirements of valid consent (condition 
2).
– Displacement of the rights-based paradigm;
– Downgrading the importance attached to/ scope of a particular 
right;
• Attacks on consent might mask the real target (the rights 
regime).
• Dilution might mean that HCPs use consent simply as the 
means to legitimise their actions.
Contemporary NBS models
A. Mandatory
B. Opt-out (screening as 
the norm)
C. Opt-in
• The lines between these 
models can be blurred 
but in model A: consent/ 
rights are not taken 
seriously
• It is easy to see how 
model B might de-centre 
and dilute consent in 
practice.
NBS Example: England
• Promotes model C (opt-in).
• Verbal/ single parent proxy consent process.
• Discussion in 3T and shortly after birth 
(supported by informational leaflet).
• Bloodspot screening for 9 conditions: some 
choice over testing/ report options.
• Proxy consent recorded in newborn records.
• Additional written formalities where parental 
veto exercised.
• Default 5 year+ storage and use for quality 
improvement/ research
• Testing presented as responsible parenting.
• Evidence suggests dilution of consent may 
occur in practice and differential views 
depending on reason for testing (Ulph et al. 
(2020)).
• Closer to an ‘opt-out’ model in practice.
Decision-making in expansionary 
mode
• Expression of gene variation is shaped by a range 
of internal/external factors, making whole exome 
or genome results difficult to interpret.
• Expansion may mean:
– Individual benefits becomes more diffuse/ remote and 
less compelling;
– Effective consent processes become more difficult as 
complexity of choices/ informational requirements 
change (Botkin 2017).
• The most likely deviation may be to regimes that 
pay lip service to opt-in.
Decision-making in expansionary 
mode
• Range of decision-
making:
– Decisions as to the scope;
– Decisions to test;
– Decisions as to reporting;
– Decisions as to data
retention and storage;
– Decisions as to research/ 
later use.
• Interests, consent processes 
and inclusion criteria may 
differ at each point.
• The demands of condition 2 
(especially informational) are 
likely to be problematic during 
periods of expansion.
• Blanket models of consent 
may not be helpful: 
– Breaking down decision-
making/ consent processes into 
separate components 
(pros/cons).
– Or stratified informational 
processes based on parental 
want.
Legitimate interests and the scope of 
parental rights
• Are parental rights based on direct interests, or derivative from the 
interests of the child.?
– Lord Scarman in Gillick [1986]: ‘[parental power and control] exists primarily to enable the parent to 
discharge his duty of maintenance, protection, and education until he reaches such an age as to be able to look after himself and 
make his own decisions’
– The problem of ‘open futures’ (Feinberg (1992))
• Framing parental consent in duty terms and as necessary to the 
extent that it serves present or future interests of the child, offers a 
platform to circumvent condition 1.
• Oviedo Convention/ Additional Protocol – most interventions 
require direct benefit for the test subject or very tight regulatory 
constraints.
• State actors/ HCPs need to balance interests: there are reasons 
(beyond rights) why condition 2 should be taken seriously: 
maintenance of trust in NBS and avoidance of legal disputes.
Challenges
1. New genetic tests create opportunities and challenges 
for the governance of NBS.
2. Mapping/ classifying NBS regimes against the ‘ideal’ 
typical consent model may be problematic: 
– the gap between promise and reality;
– multiple decision-making elements;
3. Even if the sovereignty of consent is not questioned, 
implementation of the ideal typical model will be a 
major challenge.
4. The possible pressure points do not tell from which 
ethical constituency the pressure will be applied or 
the specific form it will take.
Negotiating interests and deviation?
• Need to think carefully about higher ranking 
(overriding) rights.
• If we negotiate/ vary conditions of consent, 
can we be sure these variations will be 
respected in practice?
Closing remarks
• Pressure to expand may come from obvious 
challenges (utilitarian, paternalistic or 
communitarian ethics) 
• BUT important we do justice to any model of 
consent used.
• Expansion of NBS in ordinary times is one 
thing. 
• In extraordinary times, neither rights nor 
consent may be a focal consideration.
